Archives202520242023202220212020201920182017201620152014201320122011 February 15, 2018London Investor Evening – Monday 26 February 2018 @ 6pm Read More February 08, 2018Holding in Company Read More February 05, 2018Notification of Major Interest – Lanstead Increases Holding to over 5% Read More January 24, 2018Successful Placing to Raise £10 Million Read More January 18, 2018Completion of Lupuzor™ Pivotal Phase III Study and Initiation of Follow Up Study Read More November 28, 2017Update on Lupuzor™ Pivotal Phase III Study Read More November 28, 2017ImmuPharma PLC (“ImmuPharma” or the “Company”) Holding(s) in Company Read More November 06, 2017Successful Completion of Lanstead Sharing Agreement Read More September 27, 2017Interim Results Announcement for the six months ended 30 June 2017 Read More September 27, 2017ImmuPharma initiates preparation of Lupuzor’s™ regulatory submissions Read More September 21, 2017Update on Lupuzor™ Pivotal Phase III Study Read More July 03, 20172017 Annual General Meeting – All Resolutions Passed Read More 1…13141516
January 18, 2018Completion of Lupuzor™ Pivotal Phase III Study and Initiation of Follow Up Study Read More
